FSD Pharma Files Investigational New Drug Application ("IND") with FDA and Health Canada for Phase-2 Trial of FSD-201 for an Inflammatory disorder and Provides Corporate Updates
Stock Information for FSD Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.